Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes

Cell-free (cf) DNA screening is a noninvasive prenatal screening approach that is typically used to screen for common fetal trisomies, with optional screening for sex chromosomal aneuploidies and fetal sex. Genome-wide cfDNA screening can screen for a wide variety of additional anomalies, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Mossfield, Tamara, Soster, Erica, Menezes, Melody, Agenbag, Gloudi, Dubois, Marie-Line, Gekas, Jean, Hardy, Tristan, Jurkowska, Monika, Kleinfinger, Pascale, Loggenberg, Kelly, Marchili, Pablo, Sirica, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465083/
https://www.ncbi.nlm.nih.gov/pubmed/36105088
http://dx.doi.org/10.3389/fgene.2022.975987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465083/
https://www.ncbi.nlm.nih.gov/pubmed/36105088
http://dx.doi.org/10.3389/fgene.2022.975987

Ejemplares similares